Note that some links may require subscriptions.
Janssen's , the company said. To be sold as Symtuza, the product also contains cobicistat, emtricitabine, and tenofovir alafenamide.
A federal appeals court by hospitals slated for budget cuts under the 340B drug discount program; the court ruled that the hospitals didn't have standing to sue because they have not yet been affected by the cuts. (Modern Healthcare)
A to find a deadly disease: 3-D color X-rays. (The New York Times)
FDA tightrope walking: the agency announces a new initiative to "to include indications that have not, historically, been available for use without a prescription" -- but also without relaxing "the evidentiary standards needed" for OTC products.
Do urgent care clinics prescribe too many antibiotics? . (The Washington Post)
Eleven states are of hepatitis A. (WCYB.com)
Bill Gates and some other investors are to find a way to diagnose Alzheimer's earlier. (Business Insider)
The Toronto Board of Health is as part of a strategy to fight the overdose crisis in that country. (Globe and Mail)
CDC director Robert Redfield, MD, to the opioid crisis. (CBS News)
But the U.S. is also facing a shortage of some legitimate opioid painkillers. Now, one supplier says it's . (Reuters)
Speaking of earlier diagnosis, an experimental blood test for melanoma. (CNN)
You think you had a bad day? Try . (The Washington Post)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the 乌鸦传媒 community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.